Alireza Aminoroaya

Dr. Alireza Aminoroaya

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Composites Part B: Engineering
Verified
Journal Article
Open access
AAAlireza Aminoroaya
Alireza Aminoroaya
RNRasoul Esmaeely Neisiany
Rasoul Esmaeely Neisiany
SKSaied Nouri Khorasani
Saied Nouri Khorasani
PPParisa Panahi
Parisa Panahi
ODOisik Das
Oisik Das
SRSeeram Ramakrishna
Seeram Ramakrishna

1 January 2022 in Journal of the Mechanical Behavior of Biomedical Materials
Verified
Journal Article
Closed access
AAAlireza Aminoroaya
Alireza Aminoroaya
RBRouhollah Bagheri
Rouhollah Bagheri
SKSaied Nouri Khorasani
Saied Nouri Khorasani
ZTZahra Talebi
Zahra Talebi
PDParham Derakhshanfar
Parham Derakhshanfar
RNRasoul Esmaeely Neisiany
Rasoul Esmaeely Neisiany

23 July 2023 in Polymers
Verified
Journal Article
Open access
PDF file
NRNead Rostami
Nead Rostami
FFFarzaneh Faridghiasi
Farzaneh Faridghiasi
AGAida Ghebleh
Aida Ghebleh
HNHadi Noei
Hadi Noei
MSMeisam Samadzadeh
Meisam Samadzadeh
BSBryan Ronain Smith
Bryan Ronain Smith
Curcumin (CUR) has potent anticancer activities, and its bioformulations, including biodegradable polymers, are increasingly able to improve CUR’s solubility, stability, and delivery to cancer cells. In this study, copolymers comprising poly (L-lactide)-poly (ethylene glycol)-poly (L-lactide) (PLA-PEG-PLA) and poly (ethylene glycol)-poly (L-lactide)-poly (ethylene glycol) (PEG-PLA-PEG) were designed and synthesized to assess and compare their CUR-delivery capacity and inhibitory potency on MCF-7 breast cancer cells. Molecular dynamics simulations and free energy analysis indicated that PLA-PEG-PLA has a higher propensity to interact with the cell membrane and more negative free energy, suggesting it is the better carrier for cell membrane penetration. To characterize the copolymer synthesis, Fourier transform-infrared (FT-IR) and proton nuclear magnetic resonance (1H-NMR) were employed, copolymer size was measured using dynamic light scattering (DLS), and their surface charge was determined by zeta potential analysis. Characterization indicated that the ring-opening polymerization (ROP) reaction was optimal for synthesizing high-quality polymers. Microspheres comprising the copolymers were then synthesized successfully. Of the two formulations, PLA-PEG-PLA experimentally exhibited better results, with an initial burst release of 17.5%, followed by a slow, constant release of the encapsulated drug up to 80%. PLA-PEG-PLA-CUR showed a significant increase in cell death in MCF-7 cancer cells (IC50 = 23.01 ± 0.85 µM) based on the MTT assay. These data were consistent with gene expression studies of Bax, Bcl2, and hTERT, which showed that PLA-PEG-PLA-CUR induced apoptosis more efficiently in these cells. Through the integration of nano-informatics and in vitro approaches, our study determined that PLA-PEG-PLA-CUR is an optimal system for delivering curcumin to inhibit cancer cells.

1 December 2023 in Hypertension
Verified
Journal Article
Open access
DSDarren Story
Darren Story
AAAlireza Aminoroaya
Alireza Aminoroaya
ZSZak Skelton
Zak Skelton
MKManisha Kumari
Manisha Kumari
YZYapei Zhang
Yapei Zhang
BSBryan Ronain Smith
Bryan Ronain Smith
Nearly 1.4 billion people worldwide suffer from arterial hypertension, a significant risk factor for cardiovascular disease which is now the leading cause of death. Despite numerous drugs designed to treat hypertension, only ≈14% of hypertensive individuals have their blood pressure under control. A critical factor negatively impacting the efficacy of available treatments is their poor bioavailability. This leads to increased dosing requirements which can result in more side effects, resulting in patient noncompliance. A recent solution to improve dosing and bioavailability issues has been to incorporate drugs into nanoparticle carriers, with over 50 nanodrugs currently on the market across all diseases, and another 51 currently in clinical trials. Given their ability to improve solubility and bioavailability, nanoparticles may offer significant advantages in the formulation of antihypertensives to overcome pharmacokinetic shortcomings. To date, however, no antihypertensive nanoformulations have been clinically approved. This review assesses in vivo study data from preclinical antihypertensive nanoformulation development and testing. Combined, the results of these studies suggest nanoformulation of antihypertensive drugs may be a promising solution to overcome the poor efficacy of currently available antihypertensives, and with further advances has the potential to open paths for new substances that have heretofore been clinically unrealistic due to poor bioavailability.

27 June 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
NRNead Rostami
Nead Rostami
FFFarzaneh Faridghiasi
Farzaneh Faridghiasi
AGAiada Ghebleh
Aiada Ghebleh
HNHadi Noei
Hadi Noei
MSMeisam Samadzadeh
Meisam Samadzadeh
RHReza Heidari
Reza Heidari
Curcumin (CUR) is a phytochemical with potent anticancer activities as demonstrated by both preclinical and clinical studies. CUR bioformulations, including loading in biodegradable polymers, have been explored to increase CUR’s solubility and chemical stability, control its release, and improve its delivery to cancer cells. In this study, copolymers comprising poly (L-lactide)-poly (ethylene glycol)-poly (L-lactide) (PLA-PEG-PLA) and poly (ethylene glycol)-poly (L-lactide)-poly (ethylene glycol) (PEG-PLA-PEG) were designed and synthesized to assess and compare their curcumin delivery capacity and inhibitory potency on MCF-7 breast cancer cells. Molecular dynamics simulations indicated that PLA-PEG-PLA has a higher propensity to interact with the cell membrane and more negative free energy, suggesting it is the better carrier for cell membrane penetration. Our characterization indicated that the microsphere copolymers were synthesized successfully. Of the two formulations, PLA-PEG-PLA experimentally exhibited better results, with an initial burst release of 17.5%, followed by a slow, constant release of the encapsulated drug up to 80%. PLA-PEG-PLA-curcumin showed a significant increase in cell death in MCF-7 cancer cells (IC50 = 23.01 ± 0.85 µM) based on the MTT assay. These data were consistent with gene expression studies of Bax, Bcl2, and hTERT which showed that PLA-PEG-PLA-CUR induced apoptosis more efficiently in these cells. Our study integrates in vitro and in silico approaches to identify an optimal co-polymer for the delivery of CUR to cancer cells.